Form 8-K - Current report:
SEC Accession No. 0001854270-24-000128
Filing Date
2024-12-16
Accepted
2024-12-16 16:09:26
Documents
15
Period of Report
2024-12-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K snti-20241216.htm   iXBRL 8-K 28102
2 PRESS RELEASE a202412168kex991celestpr.htm EX-99.1 20670
6 senti_logoxpr.jpg GRAPHIC 3383
  Complete submission text file 0001854270-24-000128.txt   188397

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20241216.xsd EX-101.SCH 1785
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20241216_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20241216_pre.xml EX-101.PRE 13045
17 EXTRACTED XBRL INSTANCE DOCUMENT snti-20241216_htm.xml XML 2835
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 241551879
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)